A novel fiber-2-edited live attenuated vaccine candidate against the highly pathogenic serotype 4 fowl adenovirus
Quan Xie,Shiya Cao,Wei Zhang,Weikang Wang,Luyuan Li,Qiuqi Kan,Hui Fu,Tuoyu Geng,Tuofan Li,Zhimin Wan,Wei Gao,Hongxia Shao,Aijian Qin,Jianqiang Ye,Quan Xie,Shiya Cao,Wei Zhang,Weikang Wang,Luyuan Li,Qiuqi Kan,Hui Fu,Tuoyu Geng,Tuofan Li,Zhimin Wan,Wei Gao,Hongxia Shao,Aijian Qin,Jianqiang Ye
DOI: https://doi.org/10.1186/s13567-021-00907-z
2021-02-27
Veterinary Research
Abstract:Abstract Recently, the outbreaks of hydropericardium-hepatitis syndrome (HHS) caused by the highly pathogenic fowl adenovirus serotype 4 (FAdV-4) have resulted in huge economic losses to the poultry industry globally. Although several inactivated or subunit vaccines have been developed against FAdV-4, live-attenuated vaccines for FAdV-4 are rarely reported. In this study, a recombinant virus FA4-EGFP expressing EGFP-Fiber-2 fusion protein was generated by the CRISPR/Cas9 technique. Although FA4-EGFP shows slightly lower replication ability than the wild type (WT) FAdV-4, FA4-EGFP was significantly attenuated in vivo compared with the WT FAdV-4. Chickens infected with FA4-EGFP did not show any clinical signs, and all survived to 14 day post-infection (dpi), whereas those infected with FAdV-4 showed severe clinical signs with HHS and all died at 4 dpi. Besides, the inoculation of FA4-EGFP in chickens provided efficient protection against lethal challenge with FAdV-4. Compared with an inactivated vaccine, FA4-EGFP induced neutralizing antibodies with higher titers earlier. All these data not only provide a live-attenuated vaccine candidate against the highly pathogenic FAdV-4 but also give a potential insertion site for developing FAdV-4-based vaccine vectors for delivering foreign antigens.
veterinary sciences